COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01109030
Recruitment Status : Completed
First Posted : April 22, 2010
Last Update Posted : May 9, 2012
Information provided by (Responsible Party):
Amirhossein Modabbernia, Tehran University of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2011
Actual Study Completion Date : October 2011